Croatian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 47 displayed.
1 2 3 »

Rybelsus® (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU

Read more ››

By: GlobenewsWire - 04 Apr 2020

Novo Nordisk A/S - Share repurchase programme

Read more ››

By: GlobenewsWire - 30 Mar 2020

Resolutions from the Annual General Meeting of Novo Nordisk A/S

Read more ››

By: GlobenewsWire - 26 Mar 2020

Novo Nordisk A/S - Articles of Association

Read more ››

By: GlobenewsWire - 26 Mar 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 23 Mar 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 16 Mar 2020

Novo Nordisk pauses the clinical trials investigating concizumab (anti-TFPI mAB) in haemophilia A and B with or without inhibitors

Read more ››

By: GlobenewsWire - 16 Mar 2020

Novo Nordisk A/S: Share repurchase programme

Read more ››

By: GlobenewsWire - 09 Mar 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 02 Mar 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 24 Feb 2020

Notice for the Annual General Meeting of Novo Nordisk A/S

Read more ››

By: GlobenewsWire - 21 Feb 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 14 Feb 2020

Trading in Novo Nordisk shares by board members, executives and associated persons on 11 February 2020

Read more ››

By: GlobenewsWire - 14 Feb 2020

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 February 2020

Read more ››

By: GlobenewsWire - 11 Feb 2020

Trading in Novo Nordisk shares by board members, executives and associated persons on 5 - 8 February 2020

Read more ››

By: GlobenewsWire - 10 Feb 2020

Novo Nordisk's operating profit increased by 11% in Danish kroner and by 6% at constant exchange rates (CER) in 2019

Read more ››

By: GlobenewsWire - 05 Feb 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 04 Feb 2020

Rybelsus® (oral semaglutide) recommended for approval for the treatment of adults with type 2 diabetes by the European regulatory authorities

Read more ››

By: GlobenewsWire - 31 Jan 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 27 Jan 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 20 Jan 2020

Looking for companies outside of Croatia?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

April 2020
- : BioTrinity 2020 - DIGITAL EVENT
May 2020
- : Venture Summit | West
- Vienna: Nano Drug Delivery 2020

Add an Event »

Latest company news

There are currently no news available for this portal

Visit the global news page on Biotechgate »

Biotechgate database

About Biotechgate
The Croatian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com